Gennex Laboratories share news, announcements and annual reports
BSE: 531739Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 28 Oct 2026. Previous close ₹8.88.
28 Oct: open ₹8.80, high ₹9.21, low ₹8.80
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹221 Cr2,248th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 12.03
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.99
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 9.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 7.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.15
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 2,86,354
Gennex Laboratories share news and announcements
553 announcements, routine notices left out, newest first. Page 3 of 12.
Aug 2024
May 2024
21 May · Board meeting
Meeting on 30 May 2024: audited results
Apr 2024
29 Apr · Compliance Certificate Under Regulation 40(9) & 40(10} Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015 Of Gennex Laboratories Limited For The Year Ended March 31, Z024
25 Apr · Compliance Certificate Under Regulation 7(2) & 7(3) Of The SEBI (LODR) Regulations, 2015 Of Gennex Laboratories Limited For The Year Ended March 31, 2024
Feb 2024
1 Feb · Board meeting
Meeting on 14 Feb 2024: quarterly results
Jan 2024
Dec 2023
13 Dec · Company Obtained Good Manufacturing Practices Certificate From Drugs Control Administration, Government Of Telangana
Nov 2023
20 Nov · Board meeting
Meeting on 2 Dec 2023: increase in authorised capital and preferential issue of shares14 Nov · Disclosure Under Regulation.23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015 Of Gennex Laboratories Limited
3 Nov · Board meeting
Meeting on 14 Nov 2023: quarterly results
Oct 2023
Sep 2023
6 Sep · Corporate action
Aug 2023
29 Aug · Board meeting
Meeting on 6 Sep 2023: annual general meeting9 Aug · Company Obtained Approval Of Additional Products From Drug Control Administration, Government Of Telangana;
3 Aug · Board meeting
Meeting on 14 Aug 2023: quarterly results
Jul 2023
12 Jul · Outcome Of The Right Issue Committee Meeting Of Gennex Laboratories Limited
11 Jul · Company Obtained World Health Organization - Goods Manufacturing Practice (WHO-GMP) Certificate From Drug Control Administration, Government Of Telangana,